Research findings differentiate prostate cancer tumors into five different types
the ONA take:
Determining the appropriate course of treatment for prostate cancer can be a challenge for clinicians.
The disease can be slow growing and never cause a problem for a man or it can be an aggressive disease requiring immediate treatment.
Scientists at Cancer Research UK recently found that prostate cancer has five distinct types, and they also found a way to determine which type of tumor a patient has.
The researchers looked for abnormal chromosomes and measured the activity of 100 genes linked to prostate cancer in healthy and cancerous tissue samples from more than 250 men. They were able to group the tumors into five different types, each with its own genetic fingerprint.
The next step is to confirm their findings in larger studies that further explore how each specific type behaves.
However, the researchers report that their findings could lead to better understanding of the disease and more effective treatment for patients who have aggressive disease.
Prostate cancer has five distinct types, with different ways to determine which type of tumor a patient has.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|